Provis Biolabs
Provis Biolabs is an India-headquartered biopharmaceutical manufacturer founded in 2019 producing animal-origin-free recombinant bioreagents, custom peptides, and CDMO services for pharmaceutical, biotechnology, CDMO, and research organizations across North America, Europe, and Asia.
- Company typePrivate
- Founded2019
- HeadquartersEast Hartford, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Provis Biolabs does
Provis Biolabs is a private biopharmaceutical manufacturer founded in 2019 and headquartered in India, with a U.S. business development office in East Hartford, CT. The company develops and produces animal-origin-free recombinant bioreagents, peptides, and biosimilars for the global life sciences industry. It operates a dual expression platform spanning mammalian (CHO) and microbial (E. coli, Pichia pastoris) systems, with a catalog of 11 products that includes the proprietary endonuclease brand Provinase™, Trypsin in GMP, MS, and Trypsin-EDTA formats, Carboxypeptidase B in GMP and Sequencing grades, PNGase F and the engineered PNGase F FLASH® variant, and ancillary reagents such as Streptavidin, Enterokinase, and Kex2 Protease. Manufacturing occurs at WHO-GMP, GMP, ISO 9001, and ISO 13485 certified facilities with multi-kiloliter fermentation capacity, supplemented by Halal and Kosher certifications.
The company operates three revenue streams: catalog recombinant bioreagent sales, custom peptide synthesis via Fmoc-based SPPS with 300+ modifications, and CDMO services spanning strain engineering, upstream and downstream processing, analytical development, and commercial-scale GMP manufacturing with technology transfer. Pricing is quote-based across all product lines and grades. Go-to-market combines direct enterprise field sales with a network of authorized distribution partners spanning North America (Amerigo Scientific, Labscoop, Zageno, Cedarlane, BioScotia, and Avantor/VWR) and is reinforced by conference participation at BioProcess International, BIO International Convention, CPHI Japan and Frankfurt, MEDICA, BioAsia, and Global Biologics India. The Founder is active in industry-academia engagement, including presenting at the University of Hyderabad's Drug Discovery and Development Workshop in August 2025.
Primary customer segments include pharmaceutical companies (biologics, biosimilars, monoclonal antibody manufacturers), biotechnology firms (cell and gene therapy, vaccines, viral vectors), CDMOs, and academic and research organizations. The company reports serving customers across North America, Europe, and Asia (Japan, India, Singapore, Korea), with capacity additions underway through a new state-of-the-art manufacturing facility and ongoing R&D scale-up. No external funding rounds, revenue figures, or named end customers have been publicly disclosed.
Provis Biolabs firmographics
Firmographics- Name
- Provis Biolabs
- Legal name
- Provis Biolabs Private Limited
- Website
- https://provisbiolabs.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Provis Biolabs is an India-headquartered biopharmaceutical manufacturer founded in 2019 producing animal-origin-free recombinant bioreagents, custom peptides, and CDMO services for pharmaceutical, biotechnology, CDMO, and research organizations across North America, Europe, and Asia.
- Ownership category
- akta.pro rank
Provis Biolabs industry classification
Industry- Product category
- Recombinant Bioreagents & Biopharmaceutical Manufacturing
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)
- akta.pro secondary industries
- Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF)
Keywords
Where Provis Biolabs is headquartered
LocationHeadquarters
- HQ city
- East Hartford
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Provis Biolabs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Recombinant Bio-Reagents: Sale of catalog recombinant proteins and enzymes including Provincialase, Trypsin, Carboxypeptidase B, PNGase F, Streptavidin, Enterokinase, and Kex2 Protease. Products sold in multiple grades (Research, MS, GMP) and formats. Revenue generated through direct product sales to pharmaceutical, biotechnology, and research organizations.
- CDMO Services: Contract Development and Manufacturing Organization services covering strain engineering, upstream processing, downstream purification, analytical development, GMP manufacturing, and tech transfer. Services span from R&D through commercial-scale GMP manufacturing with multi-kL fermentation capacity.
- Custom Peptide Synthesis: Custom synthesis of peptides for pharmaceutical, biotechnology, and academic research. Services include linear, cyclic, bridged, and PEGylated peptides. Flexible quantities from mg to kg scale with guaranteed quality including MS and HPLC analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Provinase™ Endonuclease GMP Grade - Available in 100KU, 500KU, and 5MU formats |
| Unit Pricing | Pay-as-you-go | Recombinant Trypsin GMP Grade - Available in 1g, 5g, and 25g formats |
| Unit Pricing | Pay-as-you-go | Full product portfolio including PNGase F, Carboxypeptidase B, Streptavidin, Enterokinase, Kex2 Protease |
| Unit Pricing | Multi-year contract | Custom Peptide Synthesis - Flexible quantities from mg to kg scale |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels5 records
Provis Biolabs product offering
Product offeringCore offering
Provis Biolabs manufactures and sells animal-origin-free recombinant bioreagents (endonucleases, proteases, glycanases, and other enzymes) for biopharmaceutical manufacturing, diagnostics, and research applications. The company also provides contract development and manufacturing (CDMO) services spanning strain engineering, upstream and downstream processing, analytical development, and multi-kL GMP manufacturing, alongside custom peptide synthesis services using Fmoc-based solid-phase peptide synthesis.
Product overview
Provis Biolabs offers a portfolio of 11 recombinant bio-reagent products spanning endonucleases, proteases, and deglycosylation enzymes for biopharmaceutical manufacturing and research applications. The core product line includes Provinciale™ (endoclease), multiple Trypsin grades (GMP, MS, Trypsin-EDTA), Carboxypeptidase B (GMP, Sequencing Grade), PNGase F variants, Streptavidin, Enterokinase, and Kex2 Protease. These are complemented by Custom Peptide Synthesis services and full-service CDMO capabilities covering strain engineering, GMP manufacturing (mammalian and microbial platforms), and analytical development. All products are animal-origin-free and manufactured under WHO-GMP, ISO, and ISO 13485 certified quality systems.
Differentiator
Problem solved
Functional benefit
Brands
- Provinase™: Flagship recombinant endonuclease product for bioprocessing applications including host cell DNA clearance, viral vector manufacturing, and vaccine production.
- PNGase F FLASH®
Products and services
- Provinase (Endonuclease)
Quantifiable outcome
- Provinase reduces host cell DNA to 3–5 nucleotide fragments supporting regulatory limits for injectable biologics
- +2 more outcomes
Companies that use Provis Biolabs
Customer profileSegments4 records
Ideal customer profiles4 records
Provis Biolabs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Provis Biolabs partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Amerigo ScientificcoreAuthorized distributor in USA providing local sales, support, and product delivery for Provis Biolabs recombinant reagents in the Hauppauge, NY area. Contact: +1-631-629-1460 / +1-516-755-7097.
- Labscoop LLCcoreAuthorized distributor in USA providing product distribution and support services for Provis Biolabs products. Located in Little Rock, AR. Contact: +1-800-316-3081.
- ZagenocoreAuthorized distributor providing online platform access to Provis Biolabs products. Located in Cambridge, MA. Contact: +1-857-477-8479.
- CedarlanecoreAuthorized distributor in Canada providing local support and product delivery for Provis Biolabs reagents. Located in Burlington, Ontario. Contact: +1-289-288-0001 / Toll Free: 1-800-268-5058.
- BioScotia Technologies Inc.coreAuthorized distributor in Canada providing product distribution and support. Located in Halifax, Nova Scotia. Contact: +1-902-702-0795.
- Avantor ScienceCentral (VWR)coreGlobal distribution partnership through VWR/Avantor ScienceCentral providing wide product availability. VWR Corporate Headquarters located in Radnor, PA. Contact: 1-800-932-5000.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Provis Biolabs competitors and assessment
Company assessmentBroad incumbents
- Cytiva (Danaher): Global bioprocess solutions provider offering process enzymes, resins, filters, and CDMO services. Competes with Provis on both reagent supply and biologics manufacturing services.
- WuXi Biologics: World's largest biologics CDMO with extensive CHO and microbial manufacturing capacity. Competes with Provis on CDMO services for mAbs, recombinant proteins, and biosimilars at commercial scale.
- Thermo Fisher Scientific: Bioproduction, analytical reagents, and CDMO services via Patheon. Broad overlap with Provis's bioreagent catalog and contract manufacturing capabilities for biologics.
- Sartorius: Bioprocess equipment, consumables, and CDMO services across upstream and downstream. Competes with Provis on bioprocess reagent catalog and integrated manufacturing solutions.
- Merck KGaA (MilliporeSigma) Life Science: Full bioprocess portfolio including process enzymes, buffers, resins, and CDMO services via the Life Science and Process Solutions segments. Competes with Provis across both reagent catalog and biologics CDMO offerings.
Direct peers
- Codexis: Engineered enzyme specialist serving pharmaceutical manufacturing with proprietary enzyme platforms. Direct competitor to Provis's PNGase F FLASH® and engineered protease offerings, particularly in QC and process analytics.
- GenScript: Custom peptide synthesis and recombinant protein/reagent manufacturer with global catalog. Direct overlap with Provis's custom peptide synthesis service and bioreagent product lines.
- New England Biolabs (NEB): Global leader in recombinant enzymes for life science research and bioprocessing. Direct overlap with Provis's PNGase F, endonuclease, protease, and streptavidin portfolio serving similar analytical and bioprocess customers.
- Roche Custom Biotech: Supplies GMP-grade PNGase F, trypsin, endonucleases (Benzonase competitor to Provinase), and other process enzymes to biopharma. Directly competes with Provis's bioreagent product family in bioprocessing and QC workflows.
Emerging players
- AGC Biologics: Mid-to-large biologics CDMO with mammalian and microbial manufacturing across multiple sites. Comparable to Provis's CDMO service offering in scope, but at substantially greater scale and customer footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Provis Biolabs social profiles
Digital presenceProvis Biolabs compliance and trust
Trust signalCompliance5 records
Provis Biolabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Provis Biolabs leadership team
Management profileNumber of profiles
Profiles1 record
Provis Biolabs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Provis Biolabs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Provis Biolabs
What does Provis Biolabs do?
Provis Biolabs manufactures and sells animal-origin-free recombinant bioreagents (endonucleases, proteases, glycanases, and other enzymes) for biopharmaceutical manufacturing, diagnostics, and research applications. The company also provides contract development and manufacturing (CDMO) services spanning strain engineering, upstream and downstream processing, analytical development, and multi-kL GMP manufacturing, alongside custom peptide synthesis services using Fmoc-based solid-phase peptide synthesis.
Is Provis Biolabs a public or private company?
Provis Biolabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Provis Biolabs founded?
Provis Biolabs was founded in 2019. It employs 11 to 50 people.
Where is Provis Biolabs based?
Provis Biolabs is headquartered in East Hartford, United States, in the North America region.
How does Provis Biolabs make money?
Three revenue lines are on record. Recombinant Bio-Reagents are the primary driver. The others are CDMO Services and custom Peptide Synthesis.
Who are Provis Biolabs's main competitors?
Broad incumbents on record are Cytiva (Danaher), WuXi Biologics, Thermo Fisher Scientific, Sartorius and Merck KGaA (MilliporeSigma) Life Science. Direct peers are Codexis, GenScript, New England Biolabs (NEB) and Roche Custom Biotech. AGC Biologics is listed as an emerging player.
Does Provis Biolabs have an API?
No public API is recorded for Provis Biolabs.
What industry is Provis Biolabs in?
Provis Biolabs's product category is Recombinant Bioreagents & Biopharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO, with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 325414 and its SIC code is 2836.